Table 2.
UiPSCs/UiNSCs reprogramming | Reprogramming strategies | Factors | Diseases (mutations) | Major findings | References |
---|---|---|---|---|---|
UiPSCs | Retrovirus | OSKM | N.A | First reported method to generate UiPSCs with reprogramming efficiency up to 4% | [32, 52] |
Paroxysmal kinesigenic dyskinesia (PKD) (Proline-rich transmembrane protein 2 (PPRT2) c.649dupC mutation) |
PRRT2 mRNA was reduced in PKD-UiPSCs PKD-UiPSCs were able to differentiate into functional glutamatergic, dopaminergic, and motor neurons in vitro |
[59] | |||
X-linked Danon disease (nonsense mutation of the LAMP-2 gene (c.520c > T, exon 4) |
Patients’ iPSC-cardiomyocytes (CMs) lines were generated Administration of the DNA demethylation agent 5-aza-2’-deoxycytidine reactivated the silent LAMP2 allele in patients’ iPSCs and iPSC-CMs and ameliorated their autophagy failure |
[60] | |||
Lentivirus | OSKM | Systemic lupus erythematosus (SLE) | SLE patients-UiPSCs were generated | [62] | |
Cryptorchid (Cryp) (mutations in insulin-like factors 3, zinc finger (ZNF) 214 and ZNF 215 genes) | Cryp-UiPSC lines were generated | [63] | |||
Spinal muscular atrophy (SMA) (mutations of the survival motor neuron 1 (SMN1) gene) |
The neurite outgrowth was reduced in both SMA type I and III-UiPSCs derived motor neurons (MNs) Significant hyperexcitability was detected in SMA type I-UiPSCs derived MNs, but not in SMA type III-UiPSCs derived MNs |
[17] | |||
Sendai Virus | OSKM | Attention deficit hyperactivity disorder (ADHD) type 2 diabetes mellitus | ADHD-UiPSCs were generated | [67] | |
Obsessive compulsive disorder (OCD) | OCD-UiPSCs were generated | [68] | |||
Duchenne Muscular Dystrophy (DMD) (dystrophin/deletion of exon 50) | DMD-UiPSCs were generated and can be differentiated into cardiomyocytes | [69] | |||
DMD (DMD/c.497G > T; p.G166V) | DMD-UiPSCs were generated | [70] | |||
DMD (dystrophin/deletion of exon 50) (CRISPR-CAS9 generation of c.263delG in the dystrophin gene) | Reduced myofibril contractile tension, slower relaxation kinetics, and Ca2+ handling abnormalities | [71] | |||
Dilated cardiomyopathy (DCM) | DCM-UiPSCs were generated | [72] | |||
Heterozygous for a dinucleotide insertion within exon 4 of PAI-1 gene | PAI-1-UiPSCs were generated | [92] | |||
Ventricular septal defect (VSD) (ryanodine receptor 2 (RyR2) mutation (c.7448 T > G, p.L2483R) | VSD-UiPSCs were able to differentiate into cardiomyocytes but had a higher level of autophagy | [74] | |||
X-linked Alport syndrome (X-LAS) (Hemizygous COL4A5 gene mutation p.G1433V (c.4298G > T) | X-LAS-UiPSCs were generated | [75] | |||
Spinal cord injury (SCI) | SCI UiPSCs-derived neural progenitor cells were able to give rise to neurons, oligodendrocytes, and astrocytes. Grafted neural progenitor cells into the injured spinal cord survived and differentiated into neurons and glia | [76] | |||
OSK, SV40, miR302-367 | Spinal muscular atrophy (homozygous deletion of exon 7 and exon 8 of the SMN1 gene) | Conversion of the SMN2 gene to an SMN1-like gene in SMA-UiPSCs using CRISPR/Cpf1 and single-stranded oligodeoxynucleotide in UiPSCs restored SMN expression and MN differentiation | [93] | ||
SeV, KOS, Klf4 and c-Myc | Type 2 diabetes mellitus (T2DM) | T2DM-UiPSCs differentiated into neuron, astrocyte, and microvascular endothelial cells | [77] | ||
Episomal vectors | OSK and SV40LT | Hemophilia A (HA) | HA-UiPSCs-derived hepatocytes failed to produced clotting factor VIII (FVIII) | [94] | |
OSK, SV40T and miR-302-367 | Hemophilia A, Hemophilia B, Amyotrophic lateral sclerosis (ALS), Systemic lupus erythematosus, β-thalassemia | Patients-UiPSCs were generated | [80] | ||
OSKM | Down syndrome (DS) (Trisomy 21-(T21) |
T21-UiPSCs maintained chromosomal stability for more than 20 passages and were more sensitive to proteotoxic stress than euploid iPSCs T21-UiPSCs can be differentiated into glutamatergic neurons and cardiomyocytes |
[84] | ||
OSK and miR-302-367 | Phenylketonuria (PKU) | PKU-UiPSCs were generated | [73] | ||
OSKM, LIN28, NANOG and SV40LT with miR302/367 | PCSK9-mediated autosomal dominant hypercholesterolemia (PCSK9-S127R (ADH) and R104C/V114A (FHBL) mutations) |
PCSK9-UiPSCs differentiated into hepatocyte-like cells ADH-derived cells secreted less amount of PCSK9 with a reduction in low-density lipoprotein (LDL) uptake FHBL-derived cells showed a strong dcreased in PCSK9 secretion and an increase in LDL uptake Pravastatin treatment enhanced LDL receptor and PCSK9 mRNA expression, as well as PCSK9 secretion and LDL uptake |
[43] | ||
Type 2 Long QT syndrome (HERG A561P mutation) |
Patient-UiPSCs differentiated into CMs using the matrix sandwich method The HERG A561P mutation led to a trafficking defect with reduced delayed rectifier K+ current, resulting in action potential prolongation and arrhythmias |
[85] | |||
Episomal with small molecules | L-Myc, OSK, Glis1, and miR-302 cluster with inhibitor of lysine-demethylase1, methyl ethyl ketone, glycogen synthase kinase 3β, and histone deacetylase | N.A | Decreased chromosomal variation and increased Sir1 expression in UiPSCs compared with iPSCs induced using the traditional episomal system | [86] | |
Small molecules | cyclic pifithrin-α (a P53 inhibitor), A-83-01, CHIR99021, thiazovivin, NaB, and PD0325901 | Diabetes and blood disorders |
Improved the reprogramming efficiency (170-foldmore) significantly Replacement of Matrigel with autologous urine cell feeders can overcome the reprogramming failure |
[87] | |
UiNSCs reprogramming |
Small molecules with episomal vectors |
CHIR99021, PD0325901, A83-01, thiazovivin, and DMH1 with OSK, SV40T, and miR-302-367 cluster | N.A | The UiNSCs can self-renew and differentiate into multiple functional neuronal subtypes and glial cells in vitro | [88] |
CHIR99021, PD0325901, A83-01, Thiazovivin with OSK, SV40LT, c-MYC, and LIN28 | N.A | The UiNSCs generated were positive for NSC markers NESTIN, PAX6, SOX2, and OLIG2 | [90] | ||
mRNA with small molecules | OSK, GLIS1 and B18R mRNAs with purmorphamine, Forskolin,Vitamin C, and Sodium Butyrate | N.A | The UiNSCs generated can differentiate into neurons, astrocytes and oligodendrocytes in vitro and in vivo | [19] |